Source link : https://www.newshealth.biz/health-news/psa-risk-similar-with-il-23-and-il-12-23-inhibitors/
TOPLINE: In a retrospective cohort study, treatment with an IL-23 inhibitor was associated with a similar incidence of psoriatic arthritis (PsA) as treatment with IL-2/23 inhibitors in patients with psoriasis. METHODOLOGY: In the study, researchers evaluated adults with psoriasis (average age, 46 years) in the TriNetX research network. Patients received either an IL-23 inhibitor (n […]
Author : News Health
Publish date : 2024-08-02 08:10:45
Copyright for syndicated content belongs to the linked Source.